Search results
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 6 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 7 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Rare drug-resistant flu variant identified in the US, CDC says
Wisconsin State Journal· 2 days agoA rare flu variant that has shown some resistance to the most commonly used antiviral treatment has...
COVID cases rising in L.A. County and California as new subvariants make mark
LA Times via Yahoo News· 5 days agoCounty began in early July — in 2021 and 2023 — but in early May in 2022. “With traveling and...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Invivyd reports antibody neutralization of new COVID variants By Investing.com
Investing.com· 3 days agoInvivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational...
COVID is coming for Calif., and it's already hitting the Bay Area the hardest
San Francisco Chronicle· 5 days agoIf you or any of your friends have gotten sick with COVID-19 recently, you’re not the only ones:...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 7 days agoA male doctor wearing a white N95 mask gives a vaccine to an older male patient wearing a white...
Airlines are adding RNC, DNC flights. What to know if you're flying from Phoenix
The Arizona Republic· 5 days agoAmerican Airlines and United Airlines plan to add flights and seats on some routes to the convention...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1